跳至主要内容
临床试验/NL-OMON50475
NL-OMON50475招募中不适用

Phenomics and Genomics of Clozapine Pharmacotherapy - New Clozapine Users - CLOZIN New Users

niversitair Medisch Centrum Utrecht0 个研究点目标入组 200 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • -he/she is about to initiate clozapine
  • -he/she has received a diagnosis of schizophrenia, schizophreniform,
  • schizoaffective disorder or psychosis not otherwise specified
  • (DSM-IV)/(un)specified other schizospectrum psychotic disorder
  • -he/she must be able to speak and read the Dutch language
  • - he/she must be 18 years or older
  • -he/she must understand the information provided about the study and understand
  • the consequences of participating and express a willingness to participate.
  • This estimation is done by the treating physician during the informed consent

排除标准

  • - admission to a psychiatric unit involuntarily in the context of an
  • *inbewaringstelling* (IBS)
  • - when the treating physician doubts if the patient understands the
  • information/consequences of participation or the willingness to participate
  • - Patients with Parkinson*s disease

研究者

发起方
niversitair Medisch Centrum Utrecht

相似试验